These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16817760)

  • 1. HIV-1 matrix protein p17 modulates in vivo preactivated murine T-cell response and enhances the induction of systemic and mucosal immunity against intranasally co-administered antigens.
    Fiorentini S; Becker PD; Marini E; Marconi P; Avolio M; Tosti G; Link C; Manservigi R; Guzman CA; Caruso A
    Viral Immunol; 2006; 19(2):177-88. PubMed ID: 16817760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical studies on immunogenicity of the HIV-1 p17-based synthetic peptide AT20-KLH.
    Fiorentini S; Marini E; Bozzo L; Trainini L; Saadoune L; Avolio M; Pontillo A; Bonfanti C; Sarmientos P; Caruso A
    Biopolymers; 2004; 76(4):334-43. PubMed ID: 15386266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replication-deficient mutant Herpes Simplex Virus-1 targets professional antigen presenting cells and induces efficient CD4+ T helper responses.
    Fiorentini S; Marconi P; Avolio M; Marini E; Garrafa E; Caracciolo S; Rossi D; Bozac A; Becker PD; Gentili F; Facchetti F; Guzman CA; Manservigi R; Caruso A
    Microbes Infect; 2007 Jul; 9(8):988-96. PubMed ID: 17553721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 matrix protein p17 increases the production of proinflammatory cytokines and counteracts IL-4 activity by binding to a cellular receptor.
    De Francesco MA; Baronio M; Fiorentini S; Signorini C; Bonfanti C; Poiesi C; Popovic M; Grassi M; Garrafa E; Bozzo L; Lewis GK; Licenziati S; Gallo RC; Caruso A
    Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9972-7. PubMed ID: 12105273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HIV-1 matrix protein p17 can be efficiently delivered by intranasal route in mice using the TLR 2/6 agonist MALP-2 as mucosal adjuvant.
    Becker PD; Fiorentini S; Link C; Tosti G; Ebensen T; Caruso A; Guzmán CA
    Vaccine; 2006 Jun; 24(25):5269-76. PubMed ID: 16713032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functions of the HIV-1 matrix protein p17.
    Fiorentini S; Marini E; Caracciolo S; Caruso A
    New Microbiol; 2006 Jan; 29(1):1-10. PubMed ID: 16608119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
    J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of HIV-1 replication in primary human T cells transduced with an intracellular anti-HIV-1 p17 antibody gene.
    Tewari D; Notkins AL; Zhou P
    J Gene Med; 2003 Mar; 5(3):182-9. PubMed ID: 12666184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV p17 enhances lymphocyte proliferation and HIV-1 replication after binding to a human serum factor.
    De Francesco MA; Caruso A; Fallacara F; Canaris AD; Dima F; Poiesi C; Licenziati S; Corulli M; Martinelli F; Fiorentini S; Turano A
    AIDS; 1998 Feb; 12(3):245-52. PubMed ID: 9517986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses.
    Martin SJ; Vyakarnam A; Cheingsong-Popov R; Callow D; Jones KL; Senior JM; Adams SE; Kingsman AJ; Matear P; Gotch FM
    AIDS; 1993 Oct; 7(10):1315-23. PubMed ID: 8267904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cDNA encoding a single-chain antibody to HIV p17 with cytoplasmic or nuclear retention signals inhibits HIV-1 replication.
    Tewari D; Goldstein SL; Notkins AL; Zhou P
    J Immunol; 1998 Sep; 161(5):2642-7. PubMed ID: 9725267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant properties of montanide CSA 720 with a recombinant HIV P17 gag protein and synthetic peptide antigens.
    Kirkley JE; Goldstein AL; Naylor PH
    Scand J Immunol; 1996 Apr; 43(4):431-8. PubMed ID: 8668923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degeneracy and repertoire of the human HIV-1 Gag p17(77-85) CTL response.
    Kan-Mitchell J; Bajcz M; Schaubert KL; Price DA; Brenchley JM; Asher TE; Douek DC; Ng HL; Yang OO; Rinaldo CR; Benito JM; Bisikirska B; Hegde R; Marincola FM; Boggiano C; Wilson D; Abrams J; Blondelle SE; Wilson DB
    J Immunol; 2006 Jun; 176(11):6690-701. PubMed ID: 16709828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of human immunodeficiency virus type-1-specific immunity with a novel gene transport unit (GTU)-MultiHIV DNA vaccine.
    Blazevic V; Männik A; Malm M; Sikut R; Valtavaara M; Toots U; Ustav M; Krohn K
    AIDS Res Hum Retroviruses; 2006 Jul; 22(7):667-77. PubMed ID: 16831091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of recombinant influenza A virus as a vector for HIV-1 p17Gag.
    de Goede AL; Boers PH; Dekker LJ; Osterhaus AD; Gruters RA; Rimmelzwaan GF
    Vaccine; 2009 Sep; 27(42):5735-9. PubMed ID: 19647812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.
    Harrer T; Harrer E; Barbosa P; Kaufmann F; Wagner R; Brüggemann S; Kalden JR; Feinberg M; Johnson RP; Buchbinder S; Walker BD
    J Immunol; 1998 Nov; 161(9):4875-81. PubMed ID: 9794421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV p17 enhances T cell proliferation by suppressing autophagy through the p17-OLA1-GSK3β axis under nutrient starvation.
    Lu J; Jia J; Zhang J; Liu X
    J Med Virol; 2021 Jun; 93(6):3607-3620. PubMed ID: 32790080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexisting members of HIV-1 p17 gene quasispecies represent proteins with distinct antigenicity and immunogenicity.
    Birk M; Flock JI; Sönnerborg A; Sällberg M
    AIDS; 1998 Oct; 12(15):1973-81. PubMed ID: 9814865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV p17 reverses the anti-inflammatory activity of IL-4 on IL-15 stimulated monocytes and modulates their ability to secrete MIP-1 alpha.
    De Francesco MA; Poiesi C; Ricotta D; Manca N
    Virus Res; 2006 Jun; 118(1-2):170-7. PubMed ID: 16427155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8+ T-cell-mediated cross-clade protection in the genital tract following intranasal immunization with inactivated human immunodeficiency virus antigen plus CpG oligodeoxynucleotides.
    Jiang JQ; Patrick A; Moss RB; Rosenthal KL
    J Virol; 2005 Jan; 79(1):393-400. PubMed ID: 15596832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.